Literature DB >> 3103806

The adenosine receptor-mediated inhibition of noradrenaline release possibly involves an N-protein and is increased by alpha 2-autoreceptor blockade.

C Allgaier, G Hertting, O V Kügelgen.   

Abstract

The stimulation-evoked overflow of [3H]-noradrenaline from slices of the rabbit hippocampus is inhibited by alpha 2-autoreceptors as well as by adenosine (A1)-receptors. Slices of rabbit hippocampus were labelled with [3H]-noradrenaline, superfused continuously and stimulated twice electrically (rectangular pulses; 2 ms, 3 Hz, 24 mA, 5 V cm-1). Treatment of hippocampal slices with N-ethylmaleimide (NEM, 30 microM; 30 min), which functionally disturbs certain N-proteins, decreased the inhibitory action of adenosine receptor agonists like (-)-N6-(R-phenylisopropyl)-adenosine ((-)-PIA) and adenosine on noradrenaline release. Release inhibition caused by (-)-PIA (0.03-1 microM) was antagonized by NEM in a non-competitive manner in the absence and in the presence of the alpha 2-adrenoceptor antagonist yohimbine. The adenosine receptor antagonist 8-phenyltheophylline significantly increased the evoked noradrenaline release by about 15% in control slices by diminishing the inhibitory action of endogenous adenosine. In NEM-treated slices this effect of 8-phenyltheophylline was not seen. In the presence of (-)-PIA (0.1 microM), i.e. under conditions of an increased inhibitory tone, release facilitation by 8-phenyltheophylline was decreased by NEM compared to that in the respective controls. Occupation of the A1-receptor with (-)-PIA prior to and during the NEM treatment did not protect the A1-receptor-coupled signal transduction system from being affected by NEM. In the presence of the alpha 2-adrenoceptor antagonist yohimbine, the inhibitory action of (-)-PIA was strongly increased. The above results suggest the involvement of a regulatory N-protein in the A1-receptor-mediated inhibition of noradrenaline release and an interaction between the alpha 2-autoreceptor and the A1-receptor-coupled signal transduction system, possibly at the level of a N-protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103806      PMCID: PMC1916948          DOI: 10.1111/j.1476-5381.1987.tb08970.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release.

Authors:  C Allgaier; T J Feuerstein; R Jackisch; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

2.  Possible involvement of the Ni-protein in the prejunctional inhibitory effect of a stable adenosine analogue (R-PIA) on noradrenaline release in the rat hippocampus.

Authors:  B B Fredholm; E Lindgren
Journal:  Acta Physiol Scand       Date:  1986-02

3.  Uncoupling of gamma-aminobutyric acid B receptors from GTP-binding proteins by N-ethylmaleimide: effect of N-ethylmaleimide on purified GTP-binding proteins.

Authors:  T Asano; N Ogasawara
Journal:  Mol Pharmacol       Date:  1986-03       Impact factor: 4.436

4.  N-ethylmaleimide (NEM) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release.

Authors:  C Allgaier; T J Feuerstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-06       Impact factor: 3.000

5.  Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex.

Authors:  H H Harms; G Wardeh; A H Mulder
Journal:  Eur J Pharmacol       Date:  1978-06-01       Impact factor: 4.432

6.  GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels.

Authors:  G G Holz; S G Rane; K Dunlap
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

7.  Direct and indirect effects of sulfhydryl blocking agents on agonist and antagonist binding to central alpha 1- and alpha 2-adrenoceptors.

Authors:  M C Quennedey; J Bockaert; B Rouot
Journal:  Biochem Pharmacol       Date:  1984-12-15       Impact factor: 5.858

8.  Treatment with N-ethylmaleimide selectively reduces adenosine receptor-mediated decreases in cyclic AMP accumulation in rat hippocampal slices.

Authors:  B B Fredholm; E Lindgren; K Lindström
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

9.  Adenosine: an endogenous modulator of hippocampal noradrenaline release.

Authors:  R Jackisch; R Fehr; G Hertting
Journal:  Neuropharmacology       Date:  1985-06       Impact factor: 5.250

10.  Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.

Authors:  R Jackisch; M Geppert; P Illes
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

View more
  23 in total

1.  Mutual interaction of histamine H3-receptors and alpha 2-adrenoceptors on noradrenergic terminals in mouse and rat brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; B Malinowska; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

2.  Protein kinase C activation and alpha 2-autoreceptor-modulated release of noradrenaline.

Authors:  C Allgaier; G Hertting; H Y Huang; R Jackisch
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

3.  Mutual interaction between presynaptic alpha 2-adrenoceptors and 5-HT1B receptors on the sympathetic nerve terminals of the rat inferior vena cava.

Authors:  G J Molderings; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

4.  Only activated but not non-activated presynaptic alpha 2-autoreceptors interfere with neighbouring presynaptic receptor mechanisms.

Authors:  N Limberger; E A Singer; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

5.  Presynaptic alpha 2-adrenoceptor, opioid kappa-receptor and adenosine A1-receptor interactions on noradrenaline release in rabbit brain cortex.

Authors:  N Limberger; L Späth; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

6.  Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices.

Authors:  L L Werling; P N McMahon; B M Cox
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

7.  Hypertension and enhanced beta-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors.

Authors:  S Guimarães; A Albino-Teixeira; M Q Paiva
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX) alters alpha 2-adrenoceptor-mediated effects at the pre- but not at the postjunctional level.

Authors:  S Guimarães; M Q Paiva; D Moura; M J Vaz-da-Silva; A Albino-Teixeira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-12       Impact factor: 3.000

9.  Pertussis toxin does not affect the adenosine-induced inhibition of the efferent function of cardiac capsaicin-sensitive nerves.

Authors:  L Mantelli; S Amerini; A Rubino; F Ledda
Journal:  J Neural Transm Gen Sect       Date:  1993

10.  Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.

Authors:  J Gonçalves; G Queiroz
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.